(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Ukraine: Russians abduct 50 Ukrainians from border village in Sumy - 2Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
- 3Germany's first Omani LNG shipments arrive despite Middle East disruptions
- 4Netflix Faces Wider Fallout After Italy Court Orders Refunds, Price Cuts
- 5Artemis II astronauts channel Apollo 8 with a striking Earthset photo
- Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
- Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It
- ‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
- College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over
- Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- Easter Island quarry reveals how Polynesians made enigmatic stone statues
- Scientists find evidence that an asteroid contains tryptophan
- Monetary Strengthening: Assuming Command over Your Cash
